United States · FDA National Drug Code directory

VENLAFAXINE HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 75834-218_bb5cc2c4-6d14-42aa-a9af-dc29bae4f238
Product NDC: 75834-218
Form: TABLET, EXTENDED RELEASE
Composition / generic term: VENLAFAXINE HYDROCHLORIDE
Labeler: Nivagen Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20190906
Source listing expiry: 20261231

Source-listed ingredients

VENLAFAXINE HYDROCHLORIDE — 150 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-00) · 75834-218-00
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-30) · 75834-218-30
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-90) · 75834-218-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →